Detection of an alternatively spliced form of deoxycytidine kinase mRNA in the 2′-2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000
Authors:
- Ashraf Said Al-MadhounAshraf Said Al-Madhoun
- Willem J.P LovesWLWillem J.P Loves
- Jose M PadronJose M Padron
- Iannis TalianidisITIannis Talianidis
- 1 August 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (4) , 601-609
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Structure of human dCK suggests strategies to improve anticancer and antiviral therapyNature Structural & Molecular Biology, 2003
- In vitro leukemia cell models of Ara-C resistanceLeukemia Research, 2000
- Kinetic Analysis of Human Deoxycytidine Kinase with the True Phosphate Donor Uridine TriphosphateBiochemistry, 1997
- Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinaseBiochemical Pharmacology, 1995
- Mammalian deoxyribonucleoside kinasesPharmacology & Therapeutics, 1995
- New targets for pyrimidine antimetabolites for the treatment of solid tumoursPharmacy World & Science, 1994
- Kinetic studies on 2',2'-difluorodeoxycytidine (gemcitabine) with purified human deoxycytidine kinase and cytidine deaminaseBiochemical Pharmacology, 1993
- Cloning and expression of human deoxycytidine kinase cDNA.Proceedings of the National Academy of Sciences, 1991
- Human T-lymphoblast deoxycytidine kinase: purification and propertiesBiochemistry, 1989
- Deoxycytidine kinase from human leukemic spleen: preparation and characterization of the homogeneous enzymeBiochemistry, 1988